Patterns of Opioid Utilization and Aberrant Opioid-Related Behaviors (AORB) in Pediatric Sickle Cell Anemia Patients: A Systematic Review
DOI:
https://doi.org/10.65759/05c7m706Keywords:
Sickle cell disease, sickle cell anemia, pediatric, opioids, opioid utilizationAbstract
Background: Sickle cell disease (SCD) causes recurrent vaso-occlusive pain in childhood which requires opioid analgesia. Opioid utilization and aberrant opioid-related behaviors (AORB) still poorly defined in pediatric Gulf Cooperation Council (GCC) populations. Objective: This systematic review analyzed data on opioid utilization patterns, AORB, opioid use disorder (OUD), and related psychosocial factors in pediatric patients with SCD. Methods: Searches were conducted in PubMed, Web of Science, Scopus, and Embase using terms related to SCD, opioid analgesics, AORB, and pediatric. We consider original cohort, cross-sectional, retrospective, and qualitative studies involving pediatric SCD populations and reporting opioid utilization or AORB. We extract data on study setting, population, opioid-related outcomes, and main findings. Results: Seven studies were included. GCC studies was limited to one Saudi tertiary emergency department study, where morphine was used commonly for acute painful crises and administration within 60 -minutes was associated with higher chance of discharge. International claims data showed that 40% of SCD patients used opioids annually, while 3% of pediatric patients were high-dose users. OUD prevalence in adolescents with SCD was reported as 5.3% in Uganda. Additional opioid use was associated with older age, previous healthcare utilization, depression, pain catastrophizing, caregiver factors, and family support. Conclusion: Opioid utilization in pediatric SCD is affected by recurrent vaso-occlusive pain and acute care needs, data on AORB in GCC children are very limited.
References
1. Abd Elmoneim AA, Al Hawsawi ZM, Mahmoud BZ, Bukhari AA, Almulla AA, Sonbol AM, Makhdoum AM. Causes of hospitalization in sickle cell diseased children in western region of Saudi Arabia: A single center study. Saudi Med J. 2019 Apr;40(4):401-404. doi: 10.15537/smj.2019.4.24049.
2. Al Abulsalam A, Al Kindi K, Al Ghailani A, Al Sinawi H, Al Balushi N, Al Kindi S, Murthi SP, Al Fahdi A, Al Alawi M. The Prevalence and Correlates of Aberrant Opioid-Related Behaviours among Patients with Sickle Cell Disease in Oman: A cross-sectional study. Sultan Qaboos Univ Med J. 2025;25:674-80.
3. Almahmoud T, Alnashwan T, Al Kuhaimi L, Essa MF, Al Balawi N, Jamaan KA, Al-Harthy N. Management of fever and acute painful crises in children with sickle cell disease in emergency departments: a tertiary hospital experience. Front Pediatr. 2023 Jun 12;11:1195040. doi: 10.3389/fped.2023.1195040.
4. Arzoun H, Srinivasan M, Sahib I, Fondeur J, Escudero Mendez L, Hamouda RK, Mohammed L. Opioid Use in Patients With Sickle Cell Disease During a Vaso-Occlusive Crisis: A Systematic Review. Cureus. 2022 Jan 21;14(1):e21473. doi: 10.7759/cureus.21473.
5. Brandow AM, Carroll CP, Creary S, Edwards-Elliott R, Glassberg J, Hurley RW, Kutlar A, Seisa M, Stinson J, Strouse JJ, Yusuf F, Zempsky W, Lang E. American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain. Blood Adv. 2020 Jun 23;4(12):2656-2701. doi: 10.1182/bloodadvances.2020001851.
6. Brandow AM, DeBaun MR. Key Components of Pain Management for Children and Adults with Sickle Cell Disease. Hematol Oncol Clin North Am. 2018 Jun;32(3):535-550. doi: 10.1016/j.hoc.2018.01.014.
7. Buchheit BM, Joslin T, Turner HN, Wong TE. Ambulatory microdose induction of buprenorphine-naloxone in two adolescent patients with sickle cell disease. Pediatr Blood Cancer. 2021 Mar;68(3):e28766. doi: 10.1002/pbc.28766.
8. Egesa WI, Nakalema G, Waibi WM, Turyasiima M, Amuje E, Kiconco G, Odoch S, Kumbakulu PK, Abdirashid S, Asiimwe D. Sickle Cell Disease in Children and Adolescents: A Review of the Historical, Clinical, and Public Health Perspective of Sub-Saharan Africa and Beyond. Int J Pediatr. 2022 Oct 8;2022:3885979. doi: 10.1155/2022/3885979.
9. Ehrentraut JH, Kern KD, Long SA, An AQ, Faughnan LG, Anghelescu DL. Opioid Misuse Behaviors in Adolescents and Young Adults in a Hematology/Oncology Setting. J Pediatr Psychol. 2014 Nov-Dec;39(10):1149-1160. doi: 10.1093/jpepsy/jsu072.
10. Hamed NF, Alatawi YDA, AlKabbani DMZ. Prevalence, Risk Factors, and Complications of Sickle Cell Disease in Saudi Arabia: A Systematic Review. Cureus. 2024 Jul 24;16(7):e65263. doi: 10.7759/cureus.65263.
11. Han J, Zhou J, Saraf SL, Gordeuk VR, Calip GS. Characterization of opioid use in sickle cell disease. Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1359-66. doi: 10.1002/pds.4291.
12. Jastaniah W. Epidemiology of sickle cell disease in Saudi Arabia. Ann Saudi Med. 2011 May-Jun;31(3):289-93. doi: 10.4103/0256-4947.81540.
13. Kwagala C, Munube D, Abbo C, Muhwezi WW, Mwesiga EK. Prevalence and factors associated with opioid use disorder among adolescents with sickle cell disease in Mulago hospital, Uganda. Child Adolesc Psychiatry Ment Health. 2024 Sep 23;18(1):94. doi: 10.1186/s13034-024-00790-4.
14. Phillips S, Schlenz AM, D'Alton S, Johnson M, Kanter J. Patient and Family Opioid Decision-Making for Pain Management in Sickle Cell Disease: A Qualitative Study. J Pain. 2023 Jul;24(7):1240-50. doi: 10.1016/j.jpain.2023.02.023.
15. Snyder AB, Zhou M, Attell BK, Cohen LL, Carter S, Bock F, Dampier C. Opioid Use After First Opioid Prescription in Children With Sickle Cell Disease. JAMA Pediatr. 2024 Apr 1;178(4):408-410. doi: 10.1001/jamapediatrics.2023.6500.
16. Stone AL, Williams Z, McNaull M, Wilson AC, Karlson CW. Daily Associations between Child and Parent Psychological Factors and Home Opioid Use in Youth with Sickle Cell Disease. Ann Behav Med. 2020 Jan 1;54(2):61-66. doi: 10.1093/abm/kaz022.
17. Valrie C, Crawford BS, Shipman-Lacewell J, Ajibade O, Fuh B, Smith W, Sisler I. Investigating Home-Based Opioid Use Among Youth with Sickle Cell Disease Using Ecological Momentary Assessment. Pediatr Blood Cancer. 2024 Aug;71(8):e31116. doi: 10.1002/pbc.31116.
18. Zempsky WT. Evaluation and Treatment of Sickle Cell Pain in the Emergency Department: Paths to a Better Future. Clin Pediatr Emerg Med. 2010 Dec;11(4):265-273. doi: 10.1016/j.cpem.2010.09.002.
